The White House on Thursday announced measures aimed at expanding access to in vitro fertilization, including a new "most-favored nation" pricing deal with the manufacturer of a leading fertility drug.

Why it matters: The effort combines two Trump priorities: lowering drug prices and making IVF treatment more affordable. • The procedure is often not fully covered by insurance, with roughly a quarter of employers reporting coverage of IVF for their workers.

Driving the news: The White House announced a deal with drugmaker EMD Serono that includes listing its fertility drug on the government's TrumpRx portal at an 84% discount, one source said. • EMD Serono agreed to similar pricing terms that the administration made in recent deals with Pfizer and AstraZeneca, including "most-favored

See Full Page